Annual report
160A.TEDINET S100W3HY
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 85
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥17.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥17.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥12.8bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥10.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.3bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥806m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥866m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥244m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥298m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥648m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥864m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥957m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥564m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥230m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥485m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥415m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥21.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥16.0bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥14.7bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.8bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥17.2bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥13.6bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.2bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.9bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.7bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.5bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2023-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥776m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥745m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥339m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥4.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥708m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥928m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥4.5bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥884m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.3bn | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥369m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥269.74 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.81 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥171.95 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥741,514.19 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥266.57 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥55 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥38 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥800 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥800 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥81,000 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,164.14 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥785.49 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥615.49 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥555.68 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,772,670.88 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 19.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 12.7% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.2% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 13.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 29.2% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.6% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.0% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 35.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 30.6% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,576,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,030,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 60,600 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 60,600 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 560 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 879 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 811 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 721 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 680 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 639 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 55
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥17m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥184m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥184m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥1.8bn |
| Nursing Care And Senior Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥74m |
| Nursing Care And Senior Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥61m |
| Nursing Care And Senior Businessreportable segment | employees | at 2025-03-31 | 803 pure |
| Nursing Care And Senior Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥13.7bn |
| Nursing Care And Senior Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥13.7bn |
| Nursing Care And Senior Businessreportable segment | segment assets | at 2025-03-31 | ¥8.1bn |
| Nursing Care And Senior Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Real Estate Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥5.0bn |
| Real Estate Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥133m |
| Real Estate Businessreportable segment | employees | at 2025-03-31 | 12 pure |
| Real Estate Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.4bn |
| Real Estate Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.2bn |
| Real Estate Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥184m |
| Real Estate Businessreportable segment | segment assets | at 2025-03-31 | ¥10.5bn |
| Real Estate Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥5.1bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥195m |
| —segment total | employees | at 2025-03-31 | 815 pure |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥18.1bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥17.9bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥184m |
| —segment total | segment assets | at 2025-03-31 | ¥18.6bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥3.1bn |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥4m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥16m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥137m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥137m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥2.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥1.6bn |
| Nursing Care And Senior Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥105m |
| Nursing Care And Senior Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥62m |
| Nursing Care And Senior Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥12.1bn |
| Nursing Care And Senior Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥12.1bn |
| Nursing Care And Senior Businessreportable segment | segment assets | at 2024-03-31 | ¥7.1bn |
| Nursing Care And Senior Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.3bn |
| Real Estate Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Real Estate Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥85m |
| Real Estate Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥5.2bn |
| Real Estate Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥5.1bn |
| Real Estate Businessreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥137m |
| Real Estate Businessreportable segment | segment assets | at 2024-03-31 | ¥6.6bn |
| Real Estate Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥147m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥17.3bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥17.2bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥137m |
| —segment total | segment assets | at 2024-03-31 | ¥13.7bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥2.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 975
| Item | Context | Value | Unit |
|---|---|---|---|
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.4101 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 1250000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.3495 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 517000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.1445 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 162000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0453 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 152000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0425 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 152000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0425 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 127688 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0357 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 101800 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0284 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 51000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0142 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 37000 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0103 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 33000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0092 | |
| Number of shares held | CurrentYearInstant | 2583488 | |
| Shareholding ratio | CurrentYearInstant | 0.7221 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 3571500 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 35715 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesLessThanOneUnitMember | 4500 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 3576000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 35715 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | － | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | － | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | － | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 196680000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 55.00 | |
| Number of male directors and other officers | FilingDateInstant | 6 | |
| Number of female directors and other officers | FilingDateInstant | 3 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.33 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000UemuraKenjiMember | 1412000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000ItoHirotoshiMember | 152000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000MatsuoAtsundoMember | 51000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000YamamotoKoujiMember | 152000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |